Interim results from independent clinical study of ColdZyme® show duration of illness lowered by approximately 5 days
University of Kent has earlier this afternoon published interim results from the ongoing double-blind, placebo-controlled, randomized on the effects of ColdZyme and the product’s effect on treating the symptoms and duration of Upper Respiratory Tract Infections (URTI). Interim results have showed that Enzymatica's ColdZyme® oral spray reduces the amount of rhinovirus and reduces the number of sick days by approximately five days, with number of sick days being the primary endpoint of the study. The study is an independent, investigator-initiated in vivo study led by Glen Davison, professor
Radisson Hotel Group is entering the next phase of its comprehensive digital transformation to improve the guest experience with the introduction of digital keys, in partnership with Zaplox.In December 2022, Zaplox was selected as the technical partner providing digital keys to Radisson Hotel Group. As previously communicated, the agreement enables Radisson Hotel Group to utilize Zaplox middleware solution to roll out mobile keys across the portfolio, which at the time of signing consisted of 624 hotels
